198 related articles for article (PubMed ID: 29048623)
41. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.
Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM
Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854
[TBL] [Abstract][Full Text] [Related]
42. [Mechanism of thymosin beta 10 inhibiting the apoptosis
and prompting proliferation in A549 cells].
Li Z; Qu L; Zhong H; Xu K; Qiu X
Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):783-8. PubMed ID: 25404268
[TBL] [Abstract][Full Text] [Related]
43. Apoptosis induction in human lung and colon cancer cells via impeding VEGF signaling pathways.
Farzaneh Behelgardi M; Gholami Shahvir Z; Asghari SM
Mol Biol Rep; 2022 May; 49(5):3637-3647. PubMed ID: 35142981
[TBL] [Abstract][Full Text] [Related]
44. Quinacrine Inhibits ICAM-1 Transcription by Blocking DNA Binding of the NF-κB Subunit p65 and Sensitizes Human Lung Adenocarcinoma A549 Cells to TNF-α and the Fas Ligand.
Harada M; Morimoto K; Kondo T; Hiramatsu R; Okina Y; Muko R; Matsuda I; Kataoka T
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29207489
[TBL] [Abstract][Full Text] [Related]
45. Combination of nadroparin with radiotherapy results in powerful synergistic antitumor effects in lung adenocarcinoma A549 cells.
Zhuang X; Qiao T; Xu G; Yuan S; Zhang Q; Chen X
Oncol Rep; 2016 Oct; 36(4):2200-6. PubMed ID: 27498922
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of MAGEA2 has a prognostic significance and is a potential therapeutic target for patients with lung cancer.
Ujiie H; Kato T; Lee D; Hu HP; Fujino K; Kaji M; Kaga K; Matsui Y; Yasufuku K
Int J Oncol; 2017 Jun; 50(6):2154-2170. PubMed ID: 28498455
[TBL] [Abstract][Full Text] [Related]
47. Mechanism of ECM-induced dormancy and chemoresistance in A549 human lung carcinoma cells.
Keeratichamroen S; Lirdprapamongkol K; Svasti J
Oncol Rep; 2018 Apr; 39(4):1765-1774. PubMed ID: 29436672
[TBL] [Abstract][Full Text] [Related]
48. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
Qin TT; Xu GC; Qi JW; Yang GL; Zhang K; Liu HL; Xu LX; Xiang R; Xiao G; Cao H; Wei Y; Zhang QZ; Li LY
J Pathol; 2015 Nov; 237(3):307-18. PubMed ID: 26096340
[TBL] [Abstract][Full Text] [Related]
49. Enhanced invasion of lung adenocarcinoma cells after co-culture with THP-1-derived macrophages via the induction of EMT by IL-6.
Dehai C; Bo P; Qiang T; Lihua S; Fang L; Shi J; Jingyan C; Yan Y; Guangbin W; Zhenjun Y
Immunol Lett; 2014 Jul; 160(1):1-10. PubMed ID: 24698728
[TBL] [Abstract][Full Text] [Related]
50. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
[TBL] [Abstract][Full Text] [Related]
51. BMP9 inhibits the growth and migration of lung adenocarcinoma A549 cells in a bone marrow stromal cell‑derived microenvironment through the MAPK/ERK and NF-κB pathways.
Wang J; Weng Y; Zhang M; Li Y; Fan M; Guo Y; Sun Y; Li W; Shi Q
Oncol Rep; 2016 Jul; 36(1):410-8. PubMed ID: 27177272
[TBL] [Abstract][Full Text] [Related]
52. Tramadol regulates proliferation, migration and invasion via PTEN/PI3K/AKT signaling in lung adenocarcinoma cells.
Xia M; Tong JH; Ji NN; Duan ML; Tan YH; Xu JG
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2573-80. PubMed ID: 27383307
[TBL] [Abstract][Full Text] [Related]
53. SIRT3 deacetylates and promotes degradation of P53 in PTEN-defective non-small cell lung cancer.
Xiong Y; Wang L; Wang S; Wang M; Zhao J; Zhang Z; Li X; Jia L; Han Y
J Cancer Res Clin Oncol; 2018 Feb; 144(2):189-198. PubMed ID: 29103158
[TBL] [Abstract][Full Text] [Related]
54. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
Neuchrist C; Erovic BM; Handisurya A; Fischer MB; Steiner GE; Hollemann D; Gedlicka C; Saaristo A; Burian M
Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238
[TBL] [Abstract][Full Text] [Related]
55. Regulation of metastatic ability and drug resistance in pulmonary adenocarcinoma by matrix rigidity via activating c-Met and EGFR.
Chang CC; Hsieh TL; Tiong TY; Hsiao CH; Ji AT; Hsu WT; Lee OK; Ho JH
Biomaterials; 2015 Aug; 60():141-50. PubMed ID: 26000960
[TBL] [Abstract][Full Text] [Related]
56. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
[TBL] [Abstract][Full Text] [Related]
57. [The roles of holothurian glycosaminoglycan combined with cisplatin on proliferation and chemotherapeutic response in A549 human lung adenocarcinoma cell].
Jin Q; Zhu XH; Lin CZ; Zhang H; Cao YW; Ding XQ; Lyu ZH
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):252-257. PubMed ID: 29730910
[No Abstract] [Full Text] [Related]
58. The ERK-ZEB1 pathway mediates epithelial-mesenchymal transition in pemetrexed resistant lung cancer cells with suppression by vinca alkaloids.
Chiu LY; Hsin IL; Yang TY; Sung WW; Chi JY; Chang JT; Ko JL; Sheu GT
Oncogene; 2017 Jan; 36(2):242-253. PubMed ID: 27270426
[TBL] [Abstract][Full Text] [Related]
59. Mechanisms underlying regulation of cell cycle and apoptosis by hnRNP B1 in human lung adenocarcinoma A549 cells.
Han J; Tang FM; Pu D; Xu D; Wang T; Li W
Tumori; 2014; 100(1):102-11. PubMed ID: 24675500
[TBL] [Abstract][Full Text] [Related]
60. Differential expression and functions of Ehm2 transcript variants in lung adenocarcinoma.
Li S; Ma J; Si Y; Cheng S; Hu M; Zhi X; Li B; Yu H; Jiang WG
Int J Oncol; 2019 May; 54(5):1747-1758. PubMed ID: 30816447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
